Limoneira (NASDAQ:LMNR – Get Free Report) is projected to issue its Q3 2025 results after the market closes on Tuesday, September 9th. Analysts expect the company to announce earnings of $0.19 per share and revenue of $52.7580 million for the quarter. Parties can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Tuesday, September 9, 2025 at 4:30 PM ET.
Limoneira (NASDAQ:LMNR – Get Free Report) last posted its quarterly earnings data on Monday, June 9th. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.16). Limoneira had a negative net margin of 0.96% and a negative return on equity of 0.90%. The firm had revenue of $35.12 million during the quarter, compared to analysts’ expectations of $38.70 million. During the same quarter in the previous year, the company posted $0.44 EPS.
Limoneira Price Performance
Limoneira stock opened at $15.76 on Tuesday. Limoneira has a 12 month low of $14.40 and a 12 month high of $29.22. The company has a current ratio of 1.05, a quick ratio of 0.94 and a debt-to-equity ratio of 0.30. The business’s 50 day simple moving average is $15.58 and its 200 day simple moving average is $16.74. The company has a market cap of $284.78 million, a price-to-earnings ratio of -112.56 and a beta of 0.44.
Limoneira Dividend Announcement
Institutional Investors Weigh In On Limoneira
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC raised its position in shares of Limoneira by 5.6% in the second quarter. Geode Capital Management LLC now owns 397,720 shares of the company’s stock worth $6,226,000 after buying an additional 20,913 shares in the last quarter. Gabelli Funds LLC raised its position in shares of Limoneira by 4.2% in the second quarter. Gabelli Funds LLC now owns 128,000 shares of the company’s stock worth $2,003,000 after buying an additional 5,200 shares in the last quarter. Qube Research & Technologies Ltd raised its position in shares of Limoneira by 515.4% in the second quarter. Qube Research & Technologies Ltd now owns 74,124 shares of the company’s stock worth $1,160,000 after buying an additional 62,080 shares in the last quarter. Squarepoint Ops LLC raised its position in shares of Limoneira by 52.8% in the second quarter. Squarepoint Ops LLC now owns 52,108 shares of the company’s stock worth $815,000 after buying an additional 18,005 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its position in shares of Limoneira by 248.7% in the second quarter. JPMorgan Chase & Co. now owns 44,238 shares of the company’s stock worth $692,000 after buying an additional 31,552 shares in the last quarter. Hedge funds and other institutional investors own 64.35% of the company’s stock.
Analysts Set New Price Targets
LMNR has been the topic of several research analyst reports. Zacks Research upgraded Limoneira to a “hold” rating in a research note on Tuesday, August 12th. Lake Street Capital upgraded Limoneira from a “hold” rating to a “buy” rating and set a $23.00 target price on the stock in a research report on Tuesday, June 10th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $25.50.
View Our Latest Stock Report on LMNR
Limoneira Company Profile
Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates through three divisions: Agribusiness, Rental Operations, and Real Estate Development. It grows, processes, packs, markets, and sells lemons. The company also grows avocado, oranges, and specialty citrus and other crops, including Moro blood oranges, Cara Cara oranges, Valencia oranges, Minneola tangelos, Star Ruby grapefruit, pummelos, and wine grapes.
Recommended Stories
- Five stocks we like better than Limoneira
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Healthcare Pathbreakers With Long-Term Tailwinds
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Tariff-Proof Retailers Making New All-time Highs
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- With Shares Near Highs, Here’s to Watch in Broadcom’s Q3 Report
Receive News & Ratings for Limoneira Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limoneira and related companies with MarketBeat.com's FREE daily email newsletter.